Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 27
- M&A Activity
Grow Group’s Avida Acquisition Marks Bold Step Forward for UK Cannabis Stalwart
Grow Group, one of the UK’s leading medical cannabis distributors now supplying over 10,000 patients internationally, announced a major strategic shift to bring control of its operations entirely in house.
- Hemp Industry
Senate Committee Passes ‘Hemp Killing’ Legislation, But Gives Hemp Businesses 1 Year Delay
Efforts to close the so-called ‘hemp loophole’ in the US, which would have banned the sale of hemp-derived products containing any detectable amount of THC, could be postponed by a year, giving operators room to adapt their operations.
- Press releases
Grow Group Transforms UK Cannabis Distribution Landscape with Avida Medical Deal
UK Medical cannabis operator Grow Group has announced a significant expansion of its full-service UK medical cannabis distribution platform, as it launches the newly rebranded Grow Group UK.
- US & Canada
US Cannabis Rescheduling Process Has Seen no Progress 6 Months After ‘Temporary’ Suspension
The frozen US cannabis rescheduling process appears to be stuck in limbo for the foreseeable future, as the Drug Enforcement Administration’s (DEA’s) new management confirmed the process ‘remains pending’.
- Investment & Finance
Cannabis Exodus from Public Markets Continues: Celadon Announces Plans to Leave AIM and IMC Fights to Remain on NASDAQ
The exodus of listed cannabis companies from the public markets, particularly in the UK, is continuing at pace as yet another medical cannabis operator has announced plans to delist.
- Your #1 Podcast on Cannabis News
Podcast: Special Ed. | From Anecdote to Evidence: Data for Advanced Access | Releaf & Dr Anne Katrin Schlag
In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf.
- Press releases
Cronos Grows its International Footprint in Switzerland
Cronos Group announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training.
- Patient Access
US House Votes to Allow VA Doctors to Recommend Medical Cannabis in Landmark Veterans Health Bill
Doctors at the US Department of Veterans Affairs (VA) may soon be allowed to recommend medical cannabis to patients, following the passage of a landmark House spending bill that seeks to align federal veterans’ care with state-level cannabis laws.
- Press releases
SOMAÍ and Lusófona Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
The study validates SOMAÍ’s patent-pending process for producing Full-Spectrum Extract Cannabis Oil (FECO), offering new scientific evidence that bridges pharmaceutical precision with consistent, patient-friendly formulations.
- US & Canada
Delaware to Launch Recreational Cannabis Sales on 1 August
Delaware will become the 22nd US state to launch a regulated adult-use cannabis market when retail sales begin on 1 August, state officials have confirmed.
- Pharmaceutical
Standard Seed AI’s Platform Could Rewrite the Future of Cannabis Drug Discovery
At its core, Standard Seed AI’s technology has the power to scientifically validate the entourage effect, streamline drug discovery, and drastically reduce the time and cost of bringing cannabis-based medicines to market.
- Uncategorized
FSA Shifts Gears: Reformulation, THC Tolerance, and Faster CBD Approvals Appear to Be On the Horizon
This morning, the UK’s Food Standards Agency (FSA) announced some significant updates to its multi-year CBD Novel Foods approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel.
